Filter News
Area of Research
- (-) Computational Biology (2)
- (-) Fusion and Fission (3)
- Advanced Manufacturing (4)
- Biological Systems (1)
- Biology and Environment (36)
- Clean Energy (41)
- Computational Engineering (2)
- Computer Science (5)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion Energy (1)
- Isotopes (5)
- Materials (23)
- Materials for Computing (3)
- National Security (25)
- Neutron Science (15)
- Nuclear Science and Technology (3)
- Quantum information Science (2)
- Supercomputing (69)
News Type
News Topics
- (-) Biomedical (3)
- (-) Composites (1)
- (-) Exascale Computing (1)
- (-) Frontier (1)
- (-) Net Zero (1)
- 3-D Printing/Advanced Manufacturing (3)
- Advanced Reactors (6)
- Artificial Intelligence (2)
- Bioenergy (1)
- Biology (3)
- Buildings (1)
- Chemical Sciences (4)
- Computer Science (3)
- Coronavirus (1)
- Critical Materials (1)
- Decarbonization (2)
- Energy Storage (4)
- Environment (2)
- Fossil Energy (1)
- Fusion (22)
- Grid (2)
- High-Performance Computing (4)
- Isotopes (1)
- ITER (6)
- Materials (1)
- Materials Science (4)
- Microscopy (1)
- Nanotechnology (1)
- Neutron Science (2)
- Nuclear Energy (26)
- Partnerships (3)
- Physics (1)
- Security (2)
- Simulation (3)
- Space Exploration (1)
- Summit (1)
- Sustainable Energy (4)
- Transportation (2)
Media Contacts
In fiscal year 2023 — Oct. 1–Sept. 30, 2023 — Oak Ridge National Laboratory was awarded more than $8 million in technology maturation funding through the Department of Energy’s Technology Commercialization Fund, or TCF.
As renewable sources of energy such as wind and sun power are being increasingly added to the country’s electrical grid, old-fashioned nuclear energy is also being primed for a resurgence.
University of Pennsylvania researchers called on computational systems biology expertise at Oak Ridge National Laboratory to analyze large datasets of single-cell RNA sequencing from skin samples afflicted with atopic dermatitis.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.